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EDITORIAL REVIEW
The kidney in sickle cell anemia
In 1910, Herrick described the first authentic case of
sickle cell disease in a young student from Grenada in
the West Indies [1]. He records that he was "uncertain
whether the blood picture represented merely a freak-
ish poikilocytosis or is dependent on some peculiar
physical or chemical condition of the blood or is
characteristic of some particular disease." It is obvious
that this was not a "new disease" and Konotey-
Ahulu [2] notes that the disease bears many different
tribal names in Africa, and was probably well re-
cognized in that area for many centuries. In 1846,
Lebby [3] had described the clinical case of a Negro
who had "bilious intermittent and remittent fevers"
and at autopsy no spleen could be found. This patient
probably had sickle cell anemia and the spleen had be-
come atrophic as a result of numerous infarcts.
The prevalence of sickle cell anemia varies in dif-
ferent parts of the world. In Jamaica it is estimated
that approximately 11 % of the population carry the
gene for S hemoglobin and the homozygous disease
occurs in 0.2°/ of the people. In Curacao the compar-
able figures are 6.5% and O.3%. The genetic basis of
the disease was recognized by Emmel [4] and was
firmly established by the study of Pauling et al [5]. It is
now known that the abnormality of the sickle cell
hemoglobin consists of the substitution of valine for
glutamic acid in position 6 in the beta-chain. The fact
that the kidney might be involved in sickle cell anemia
was recognized very early, and in Herrick's original
reports he mentioned the presence of urinary casts,
leukocyturia, a slightly increased diuresis and urine of
low specific gravity. In 1923 Sydenstricker, Mulherin
and Houseal first described macroscopic and micro-
scopic studies of the kidney on necropsy [6], and after
a hiatus of 25 yr, reports of functional studies began to
appear. The present review examines some of the older
as well as the more recent information on the mor-
phology of the kidney in sickle cell disease, the func-
tional changes which occur, as well as the clinically
significant syndromes with which the patient may pre-
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sent. In addition, some attempt is made to correlate
the anatomic and functional changes.
Structural changes
Gross changes. The kidneys of sickle cell (SS)
patients who die of nonrenal causes are grossly little
different from those of other patients. Fig. I shows that
kidney weights from Jamaican SS patients were fairly
evenly distributed with respect to controls. In kidneys
removed because of severe hematuria, submucosal
hemorrhages in the pelvis, medulla and cortex have
been described [7, 8].
Margulies and Minkin [9] found caliectasis on
pyelographic examination in 59% of 17 adult SS
patients. Autopsy studies on three patients with
caliectasis showed acute and chronic pyelonephritis,
and these authors considered caliectasis to be indic-
ative of pyelonephritis. Radiographic changes more
specific for papillary necrosis—medullary cavitation,
ring shadows and calcification in the pyramids—have
also been reported [8, 10].
Changes in the microvasculature. The essence of the
fine changes which occur in the sickle cell kidney is the
disturbance of the microvasculature. It is easy to en-
visage that in the relatively hypoxic medulla, blood
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Fig. 1. Kidney weights of Jamaican SSpatients. Each point repre-
sents the combined kidney weights. The continuous line repre-
sents the average normal values derived from the data of
COPPELLETTA JM, WOLBACH SB: Body length and organ weights
of infants and children. Am J Pathol 9:55-59, 1933.
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flow will be slow, sickling will occur, with consequent
increase in the viscosity of the blood and further slow-
ing of the circulation. The "vicious viscous cycle" has
been incriminated in the initiation and perpetuation
of sickle cell thrombosis in various tissues. Unfortun-
ately, there is not always a good correlation between
hypoxia and numbers of sickled cells in vivo and the
possibility has been raised that the venous engorge-
ment with sickle cells seen at autopsy may not repre-
sent the situation seen in vivo, and there may actually
be increased flow through those areas where the
capillaries appear congested and engorged. In Curacao,
microradioangiographic studies were performed on
kidneys from cadavers with normal hemoglobin, sub-
jects with SS disease and subjects with hemglobin AS
and SC [2, 11] (Fig. 2). A significantly reduced number
of vasa recta were seen in kidneys from SS patients.
Even those vessels which were present were abnormal
in that they were dilated, formed spirals, ended bluntly
and many appeared to be obliterated. Patients with
hemoglobin AS and SC showed changes intermediate
between those of the SS patients and the normal sub-
jects. In the AS patients, sparse bundles of vasa recta
were surrounded by a chaotic pattern of dilated
capillaries, with loss of original bundle architecture.
The natural assumption is that these changes represent
the structural basis for the development of the func-
tional changes.
Microscopic changes. The first description of struc-
tural changes in the kidneys was by Sydenstricker et
a! [6], who described prominent glomeruli distended
with blood, necrosis and pigmentation of tubular
cells. This description has been supplemented, but not
altered substantially. One important point which has
been stressed is that glomerular enlargement and con-
gestion are more frequent in children and are most
marked in the juxtamedullary glomeruli [12, 13]. In
the older patient glomerular scarring and fibrosis may
be seen [14], but even in this age group when there is no
clinical evidence of renal disease, the changes may be
very mild indeed. The glomerular changes resemble
those seen in children with cyanotic heart disease
which shares with sickle cell anemia a similar pattern
of tissue hypoxia and anoxia [15].
The medullary lesions are the most prominent, with
early changes consisting of edema progressing to focal
scarring and interstitial fibrosis. With progressive
scarring there is tubular atrophy and infiltration with
round cells. Iron deposits in the cell are a typical
feature, and pigment casts may be seen.
Ultrastructural changes. In a study of three patients
with the nephrotic syndrome and marked renal in-
sufficiency, striking changes were noted [16]. There was
fusion of the epithelial cell foot processes and sheets of
epithelial cytoplasm covered the external surface of
the basement membrane; there were also mesangial
matrix proliferation and basement membrane duplica-
tion. Another marked feature was the appearance of
electron-dense bodies, particularly in the mesangium
and occasionally in the endothelial cytoplasm. More
recently, deposits of IgG, 1gM and C3 have been noted
in glomeruli of an SS patient [17] and it has been
postulated that renal tubular insufficiency may lead to
release of renal tubular epithelial antigen with auto-
Fig 2. Injection ,nicroradio-
angiographs of kidneys from an
individual with no hemoglobino-
pathy (a) and from a patient
with sickle cell anemia (b). In
the normal kidney vasa recta
are visible radiating into the
renal papilla; in sickle cell
disease vasa recta are virtually
absent. (Reproduced from
Lancet 1:450—452, 1970,
through the courtesy of the
Editors.)a b
The kidney in sickle cell anemia 373
sensitization leading to immune-complex nephritis. In
a patient who did not have clinically significant renal
disease, the glomerular ultrastructural changes were
nonspecific [18]. There was focal fusion of foot pro-
cesses, with some granular deposits in the glomerular
basement membrane, and some thickening of the
tubular basement membrane.
Functional changes
Urinary dilution and concentration. Patients with
sickle cell anemia have been found to dilute their
urine normally [19—21]. Hatch, Culbertson and Diggs
[21] showed that under conditions of a water diuresis
the fall in urinary osmolality as water diuresis pro-
gressed was the same in control subjects and SS
patients, and the percentage of glomerular filtrate
excreted in the urine was identical in the two groups.
It would thus appear that the capacity to reabsorb
sodium in the loop of Henle and distal tubule is intact
in sickle cell anemia.
However, an inability to concentrate the urine
appropriately has been the most consistent feature of
the sickle cell nephropathy [19—23] and in the older
adult the maximum concentration is about 400 mOsm/
kg (Fig. 3). It has been observed that in very young
children with sickle cell anemia the concentration de-
fect can be restored to normal with multiple transfu-
sions of Hb A erythrocytes [19, 22]. This capacity for
inprovement is progressively lost with age, being al-
most negligible in subjects older than 15 yr (Fig. 4).
How can one explain this loss of urinary concentration
when the ability to reabsorb sodium and dilute the
urine is normal?
When Hatch et al [21] infused normal subjects and
SS patients with mannitol, free water reabsorption
(T°H20) rose to a maximum and reached a plateau as
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Fig. 3. Relationship between renal concentrating capacity and age
in normal individuals (Hb AA), sickle cell trait (AS), sickle cell
anemia (SS), sickle cell-hemoglobin C disease (SC), hemoglobin C
trait and disease (AC and CC). The upper shaded area covers the
normal range (mean, 1058 sr 128 mOsm/kg of H20); the
lower shaded area, the range of maximal urinary osmolality of
HbSS patients 10 yr and older (mean, 434 SD 21 mOsm/kg of
H20). The latter has been designated the fixed maximum of
sickle cell nephropathy. (Reproduced from Clin Chem Acta 27:
501, 1970, through courtesy of the Editors.)
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Fig. 4. Relationship between age and the effect of blood transfu-
sions in reversing the defect in urinary concentration in patients
with sickle cell disease. The upper figure represents the maximal
urinary osmolality achieved prior to transfusion (lower point of
each vertical line) and after multiple transfusions with normal
blood (upper point of each vertical line) in 14 patients with sickle
cell disease ranging in age from 2 to 40 yr of age (8 patients,
thick lines: from STATIU5 VAN EPs LW et at: C/in Chim Acta 17:
449, 1967; and 6 patients, thin lines: from KEITEL HG, et al:
J C/in Invest 35: 998, 1956).
the osmolar clearance (Cosm) increased. In controls
undergoing diuresis with 3°/ saline, the TCH2O curves
rose progressively as the Cosm increased, but never
reached a plateau. It was suggested that this was the
result of increasing sodium reabsorption across the
ascending limb of the loop of Henle, enhancing solute
accumulation in the medulla and thereby increasing
free water reabsorption. In SS patients, the TCH2O
curves were the same with saline and mannitol. Since,
as has been mentioned above, there is no apparent de-
fect in reabsorbing sodium in the distal segment, the
reason for the difference in saline curves between con-
trols and SS patients might be due to the fact that the
SS patients could produce, but could not maintain, a
high concentration of solute in the medullary inter-
stitium.
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The reason for this defect can be sought in the sick-
ling process per se, or in the disturbance of the micro-
vasculature to which we have already referred [11]. It
has been demonstrated that SS erythrocytes, when
placed in surroundings as hyperosmotic as the renal
medulla during hydropenia, will become sickled within
seconds [24]. Sickling causes a significant increase in
blood viscosity which will impede the normal circula-
tion through the vasa recta, preventing an optimal
medullary osmolality, and in this way perhaps de-
presses concentrating capacity. It is obvious that this
disturbance will be self-limiting, as a decrease in
medullary osmolality will prevent further sickling. In-
creased viscosity of blood and aggregation of erythro-
cytes with local hypoxia will finally lead to infarction
and disruption of medullary blood supply.
The vasa recta provide the main blood supply to the
inner medulla and papilla; thus, it is at these sites that
we find the most conspicuous lesions of established
sickle cell nephropathy, e.g., focal scarring and patchy
interstitial fibrosis. As these lesions take many years to
develop, it is probable that collaterals will be formed.
These collaterals will lack the highly specialized spatial
configuration—designated zonation [251—of the nor-
mal vasa recta which run parallel to the long loops of
Henle in the inner renal medulla, and are so necessary
for countercurrent diffusion and exchange. The loss of
zonation, and loss of countercurrent exchange function
of the vasa recta, means that even with normal or re-
duced absolute flow through the medulla, there will be
washout of solute, and the SS kidney will not be able
to maintain the high medullary osmolality necessary
to achieve a high concentration of urine. It has also
been suggested [13] that the concentration defect in
the sickle cell nephropathy resembles that seen in the
papillectomized rat [26] and SS patients have under-
gone a functional papillectomy.
How do these explanations of increased solute wash-
out or functional papillectomy fit with the observation
that the defect is present in the very young and is
reversible with transfusion? Perhaps in the child, be-
fore the stage of infarction and fibrosis is reached the
increased viscosity of the blood flowing through the
medulla does lead opening of new vascular channels,
which may thus promote solute washout and make it
impossible to maintain an appropriate medullary
osmolality.
Loss of the ability to concentrate the urine better
than 400 mOsm/kg is not at all incompatable with life.
Man normally drinks more fluid than is strictly neces-
sary to excrete the solute load on his kidneys, his
obligatory urine volume being about 600 ml or less per
day. The obligatory volume would amount to about
2000 mI/day in SS patients, which is not a very unusual
amount in normal subjects. Fluid deprivation or ex-
cessive fluid loss, however, will cause dehydration and
an increase in plasma osmolality more rapidly in SS
patients. The clinician should be aware of this when
adjusting the fluid balance in sickle cell patients,
especially in hot climates and in clinical syndromes
attended by vomiting, diarrhea, excessive fluid loss
and insufficient fluid intake.
Acid-base status and urine acidUlcation. It is known
that a fall in pH is associated with increased sickling
in vitro; hence, it was logical to examine the acid-base
status of patients with sickle cell anemia to determine
whether there was significant acidosis in the steady
state or during a crisis, and if any such acidosis could
be caused by a renal lesion. Indeed, painful crises have
been provoked by making patients acidotic by ad-
ministration of ammonium chloride or + acetazole-
amide [27, 28]. In Jamaica in SS patients in the steady
state, there is a mild respiratory alkalosis, and when
such patients have a painful crisis, there is no evidence
of a metabolic acidosis [29] (Table 1). It had been re-
ported from Tennessee that a metabolic acidosis was a
major factor in the production of the painful crisis [30]
but subsequent data from this group show that this is
not a constant finding [31]. The concept that a meta-
bolic acidosis occurs in, or precipitates, a painful
crisis prompted the use of bicarbonate infusions as a
routine measure in the management of these patients,
but clinical experience has not shown that there is any
consistent benefit from this therapy.
The ability of 55 patients to acidify the urine has
been investigated in Curacao [32] and Jamaica [29,
33], and in both places it has been shown that there is
a defect in urine acidification in response to an acid
load. In Jamaica, 14 adult SS patients were given am-
monium chloride (0.1 g/kg of body wt) and the results
for controls, SS patients and patients with sickle cell
trait are shown on Table 2. Compared with controls,
the patients with sickle cell anemia did not achieve as
low a urine pH. Titratable acid and total hydrion ex-
cretion were lower in the SS patients. Ammonia ex-
cretion and total hydrion excretion were also lower in
the patients with sickle cell trait. In the same study it
Table 1. Acid-base status in controls, patients in the steady state
and during painful crisisa
ph Total CO2
,nEq/liter
Pco2
mm Hg
Controls 7.355 27.3+1.9 48±4
SS patients 7.371 26.0± 1.4 44±3
SS patients in crisis 7.40 25.6± 2.0 41±5
a Values are means SD.
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Table 2. Results of ammonium chloride loadings
Group Minimum
pH
TA
p.Eq/min
NH
p.Eq/min
Total H
iEq/min
Control (10) 4.83±0.13 30.1±7.6 50.2±15.1 80.3±18.3
SS patients (14) 5.38±0.07 19.8±3.6 41.5±7.8 61.3±9.9
AS patients (4) 4.93±0.14 25.3±3.3 36.6±9.8 61.9± 11.2
Acid excretion is for two to eight hours after NH4CI administration and is corrected to 1.73 m2 body
surface area. Values are means 5D. Number of patients in parentheses.
was shown that patients with a similar degree of ane-
mia caused by iron deficiency had a reduction in am-
monia excretion, although the minimum urine pH
reached was the same as in the contlols. The factors
which could lead to a reduced renal capacity to pro-
duce ammonia in anemic patients have not yet been
elucidated.
The reduction in acid excretion in SS patients was a
function mainly of a reduced titratable acid, and the
ammonia excretion was appropriate for the urine pH
in most cases. When a maximal acidifying stimulus
was used—i.e., sodium sulphate infusion in patients
actively reabsorbing sodium—the SS patients could
lower their urine pH to the same level as the controls.
There was no difference in bicarbonate handling
between SS patients and control subjects.
The conclusion reached was that SS patients have a
mild form of incomplete renal tubular acidosis, which
must be further classified as distal rather than proxi-
mal. It has been shown in Curacao [32] that the greatest
defect in acidification tends to occur in those patients
with the most severe defect in urine concentrating
ability. It is therefore tempting to regard the two
lesions as interrelated and resulting from the obstruc-
tive vascular lesions which occur.
Distal-type renal tubular acidosis occurs when an
appropriate blood to urine hydrogen ion gradient
cannot be established by the cells of the distal tubule.
It is more than likely that this defect results from some
intrinsic inability of the distal nephron cells to secrete
hydrion. This defect could result either from some
metabolic defect interfering with cell function or or-
ganic destruction of cells. There is no evidence to pro-
pose the former in sickle cell anemia, but there is
evidence that the medullary microvasculature is so dis-
turbed that the latter possibility is a real one. The mild
renal tubular acidosis is probably not clinically signi-
ficant. There is the theoretical possibility that the defect
may be significant in patients with urinary tract in-
fections in whom an acidifying agent is given thera-
peutically, but this is unlikely to be of critical impor-
tance at this time when the agents for the treatment of
urinary tract infections are so many and varied.
Water and electrolyte excretion. Adequate hydration
is important in SS patients, and it has been observed
that symptoms suggestive of an impending crisis may
be provoked by water deprivation [34]. It has been
shown that the plasma, total blood and extracellular
volumes are supranormal in the SS patient in the non-
crisis steady state [35]. The demonstration of a supra-
normal total extracellular volume with a normal
plasma sodium concentration indicates an expanded
sodium space. Sodium conservation is very effective,
and when SS patients were placed on a low sodium
diet and in addition given 9-a-fluorohydrocortisone
(2 mg) over the last 12 hr of urine collection, their 24-
hr urine sodium fell from a control value of 199 mEq
to a value of 34 mEq. Similar figures for normal adults
were 203 and 31 mEq [36].
In contrast with normal controls, the diurnal
rhythm of urine, solute, sodium, potassium, osmolar
and free water clearances are either reversed or absent
in the SS patient [37]. The nocturia and enuresis which
are common clinical features of sickle cell disease are
the consequence of the polyuria and the absent or re-
versed diurnal excretion of urine.
Exposure to cold is well known to provoke sickle
cell crisis [38, 39]. Exposing the SS patient to a cold or
cool environment, in addition to causing a redistribu-
tion of the circulation prejudicial to peripheral areas,
induces a diuresis which aggravates the existing poly-
uria. In SS patients living in Ghana,joint or bone pain
is a common complaint in the cool or cold season of
the year, and the highest incidence of crisis is during
the cool rainy season [39]. Therefore, those aspects of
renal function which, when altered, could influence the
volumes of plasma and extracellular spaces have been
studied when Ghanaian SS patients were exposed
acutely to temperatures of 40 and 20°C (Table 3).
These two temperatures correspond to the highest
and lowest environmental temperatures achieved
in Southern Ghana where the studies were carried
out.
Effective renal plasma flow (EFFF) and giomerular
filtration rate (GFR). In normal people living in either
tropical or temperate climates, EFPR and GFR are
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Table 3. Effects of acute temperature change on various renal functions in sickle cell (55) patients and normal controls (AA)0
Observations AA 55 patients
20°C 40°C % Change 20°C 40°C V0 Change
V, mI/kg/hr
GFR, ml/min/I.73M2
ERPF, ml/min/1.73M2
V—Cosm, mI/mi,,
UosmV, mOsm/min
UNaV,LEq/min
UV, p.Eq/min
13.2±0.8
90±2.3
564±45
8.8±0.8
1.54±0.03
304±36
65±5.6
8.4±0.51
79±3.7
509±66
2.9±0.4
1.54±0.13
256±54
45±5.0
36
12
10
66
0
16
31
17.4±0.9
110±9.2
705±46
9.5±0.7
1.73±0.16
500±60
98± 11.4
11.6± 1.1
95±8.9
605±49
4.3±0.8
1.74±0.11
313±40
87± 10.0
34
13
14
55
0
37
11
a Values are the means 5EM for 19 sickle cell patients and ten controls, Osmotic and water diuresis induced by infusing 0.3M mannitol
and ingesting 400 ml of water/4 hr. Same diet eaten, containing sodium, 170 mEq/day, and potassium, 75 mEq/day, at least three days
before study. V = urine flow rate. V—Cosm = free water clearance. I.JN0V and UKV are solute, sodium and potassium excretion,
respectively. GFR and ERPF are glomerular filtration and estimated renal plasma flow corrected for body surface area.
lower in hot than in cold environments [40, 41]. In
normal controls and SS patients, elevation of the
ambient temperature produced reductions in ERPF
similar in degree. Similarly, GFR was higher at 20°C
than at 40°C in both groups. Therefore, in regard to
the renal vascular system, the sickle cell subject and
the normal individual appear to possess similar sensi-
tivity to temperature change. The increased intrarenal
resistance during heat exposure is part of a generalized
increased splanchnic vascular resistance which attends
exposure to heat, simultaneously with a decrease in
peripheral vascular resistance. The reverse occurs at
the cool temperature. The view is held that at high
ambient temperatures, the increased intrarenal vas-
cular resistance is mainly in the postglomerular vessel,
probably efferent arteriole [40, 41]. It is unclear
whether this is applicable to the subjects studied here,
inasmuch as the direction and magnitude of changes
in the filtration fraction in the individual cases lacked
consistency.
Urine flow and solute excretion. During a combined
water and osmotic diuresis, we observed a greater
urine flow rate in patients than in normal controls at
both 20 and 40°C [42]. If these observations could be
extrapolated to more normal conditions, when diuresis
is not artificially induced, then exposure to cool or
cold environment would be a greater disadvantage to
the SS patient than to the normal person with hemo-
globin AA because the former would have a greater
cold diuresis superimposed on his polyuria. The cause
of the increased urine flow in the 55 patients has not
yet been established. The renal handling of solute and
water during acute temperature change has been
analyzed in the normal person and the SS patient
(Fig. 5). In interpreting the data, urine flow (V) is used
as a rough estimate of the rate of delivery of filtrate to
the distal nephron, and V—Cosm, to approximate
sodium reabsorption in the ascending limb of the loop
of Henle. This is justifiable because a brisk water diu-
resis was produced. The lower slope of the composite
curves at 40°C for the normal controls is interpreted as
indicating a greater rate of sodium reabsorption per
unit of fluid delivered to the distal nephron at 40°C
than at 20°C, and that this is indicative of a shift of
filtration from largely cortical to largely juxtamedul-
lary glomeruli. It is argued, therefore, that the curve
for the controls at 20°C repreents mainly cortical
nephron activity, and at 40°C, mainly juxtamedullary
nephrons. The lack of segregation between the values
at 20°C and those at 40°C in the SS patients suggests
that they have a functionally uniform population of
nephrons. The almost identical slopes for the SS
patients (20 and 40°C) and for the controls at 20°C
also suggest that the entire nephron population in the
former is functionally similar to the cortical nephrons
of the latter.
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Fig. 5. Relationship between urine flow (V) and free water clear-
ance (Vcam) in normal Hb AA controls (AA) and sickle cell
patients (SCP). Open circles = values at 40°C; closed circle =
values at 20°C. Regression equations as follows: AA at 20°C:
y=1.29x+2.9 (r=+0.96). AA at 40°C: y=0.39x +7.3 (r=
+ 0.86). Note: No differentiation between 20 and 40°C values in
the SCP; 20 and 40°C intermixed. Equation for pooled 20 and
40°C results: y=l.Ox+5.8 (r= +0.91).
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Clinical manifestations of sickle cell nephropathy
Hematuria. This is the most dramatic of the renal
manifestations of sickle hemoglobinopathy. Massive
hematuria associated with sickle cell anemia was first
reported by Abel and Brown [43], but it was a report of
seven similar cases by Goodwin, Alston and Semans
[44] which first emphasized the significance of this as
more than a chance association. Since that time hema-
tuna has been reported in sickle cell trait, sickle
thalassemia, sickle=hemoglobin C and other com-
binations of hemoglobin S with abnormal hemoglo-
bins. Lucas and Bullock [45] reviewed 124 cases of
hematuria in sickle cell disease. The typical patient
was a young man with painless, gross hematuria
following mild trauma to the renal area. Bleeding
occurred from the left side in 80% of cases and was
bilateral in only 1l%. A similar predilection for the
left side has been noted [7, 46] but others have found
an equal incidence of bleeding from the two sides, and
remarked that recurrences were usually on the ipsi-
lateral side [47]. The type of hemoglobinopathy was
stated in 64 of the cases reviewed by Lucas and
Bullock [45]: 11 % had SS, 62% had AS and 27% had
SC genotypes. Other authors have remarked on the
rarity of cases associated with Hb SS. Thus, Allen [47]
had electrophoretic results in 22 of 29 cases but could
find only 1 patient with Hb SS. This rarity is more
apparent than real, for the sickle cell trait is roughly
40 times more common than the homozygous state.
Pyelographic abnormalities, most commonly a pelvic
filling defect, occurred frequently, and, coupled with
protracted hematuria, may have led to frequent
surgical intervention in the past. Currently, despite the
failure of conservative therapy to influence the bleed-
ing, it is recognized that the majority of cases will remit
spontaneously. A recent report of a transitional cell
carcinoma of the renal pelvis in association with HbAS
and a history of episodic painless hematuria over a
two-year period highlights the necessity for full uro-
logical assessment in all cases [48]. Serial studies
should be done when filling defects are found and ex-
ploration be considered if these defects persist. Surgery
will also be required in the presence of exsanguinating
hemorrhage.
Urinary tract infection and pyelonephritis. In an
analysis of pregnant females the prevalence of asymp-
tomatic bacteriuria was found to be l3.9% in women
with sickle cell trait and 6.4% in women with normal
hemoglobin [49]. A similar twofold increase in the
prevalence of asymptomatic bacteriuria has been re-
ported in pregnant Jamaican women with the sickle
cell trait [50]. In an autopsy study of 401 consecutive
cases in Jamaica in whom hemoglobin electrophoresis
findings were available, it was found that l8% of
33 patients with Hb AS had pyelonephritis as com-
pared with 9% of 299 patients with Hb AA [51]. One
patient with Hb SS had no pyelonephritis. From a
study of the autopsy protocols of 31 SS patients, these
investigators found 2 patients (7%) who had pyelo-
nephritis. An increased prevalence of pyelonephritis at
autopsy therefore correlates with an increased pre-
valence of bacteriuria in association with Hb AS. The
low incidence of pyelonephritis in SS patients was
attributed to the fact that 50°/ of them were below the
age of 10 yr.
Proteinuria and the nephro tic syndrome. Appreciable
proteinuria is a frequent finding in sickle cell disease.
occurring in 17 of 54 patients in one review [52]. Less
common is proteinuria of nephrotic proportions.
Berman and Schreiner recorded the first two examples
of the nephrotic syndrome in sickle cell disease [53],
and further reports of this association soon followed
[54, 55]. Schreiner described four patients in whom
focal asymmetrical glomerular hyalinization and
"membranous thickening" were seen at biopsy [56].
"Suggestive thickening" of the basement membrane,
increases in Periodic acid-Schiff-positive material in
the axial regions of glomeruli and duplication of the
basement membrane have been described [55]. De-
posits of iron complexes have been noted in the mesan-
gial regions and these have been considered to have a
pathogenic role in the production of the nephrotic
syndrome [16]. There are, however, grave doubts as to
whether the histological changes reported are specific
for sickle cell disease or merely coincidental, and our
experience in Jamaica has indicated a close association
between proteinuria, chronic ulceration of the legs and
streptococcal infection.
Renal function in relation to age
Aging is a contributing factor in the renal disorders
of sickle cell anemia [19, 20, 23]. Homozygote SS
patients under 30 yr of age have, as a rule, normal
GFR and ERPF. In SS infants, increased values have
been observed, both for GFR and ERPF, as well as for
the tubular maximum of para-aminohippurate
(Tm) [23, 57]. In older SS patients (16 to 40 yr),
these functions have been found to diminish with age
to normal or even somewhat depressed levels [58, 591.
In older adults a decrease in GFR out of proportion
to that in ERPF has been noted. On the other hand,
SS patients in their 40's or even older have sometimes
been observed to have completely normal or even
supranormal GFR and ERPF (Table 4).
Multiple transfusions with Hb A blood to SS
patients result in significant—although temporary—
increases in hemoglobin concentration, with gradual
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Table 4. Data on four female SS patients, showing high GFR even above the age of 40 yr
Patient
No.
Age
yr
Hemo-
globin
g/100ml
Urine max
concentration
mOsm/kg ofHaO
Plasma
creatinine
mg/100 ml
Cr,t
mi/mm mi/mm
CrAu
mi/mm
1 40 9.8 0.50 155 135 835
43 9.2 501 0.45 180
45 9.2 0.40 215
2 50 8.3 424 0.44 168
56 9.1 0.80 85 120 800
58 9.6 0.60 115
3 49 9.3 378 0.80 110
4 37 8.1 0.55 147
but almost complete replacement of Hb S by Hb A.
Since this procedure does not reduce the supranormal
GFR and ERPF [22], the cause of this increase in
renal hemodynamics in sickle cell nephropathy cannot
be explained by the anemia per se, or by the presence of
the abnormal hemoglobin concentration. Besides,
GFR and ERPF have been found to be slightly re-
duced in chronic anemia from other causes, both in
man [60] and in dogs [61].
The fact that renal function does deteriorate with
age means that as SS patients are better treated and
live longer, there will be increasing numbers of them
presenting to renal units with chronic renal failure.
There are as yet no reports identifying such older SS
patients whose renal function has deteriorated purely
as a result of the disease to the point at which dialysis
has become necessary. However, the increasing aware-
ness of the renal problems of the SS patient is already
becoming clearer, and it has been shown that such
young patients with renal failure may be treated with
repetitive hemodialysis and do not seem to have any un-
toward complications [62]. The problem of treatment
of renal failure in SS patients will be compounded by
the fact that the majority of them live in countries
where there are inadequate facilities for support of
patients with chronic renal failure.
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